How have the shares performed?
Radius Health Inc. (RDUS) saw downtrend of -2.82% in the recent trading with $19.29 being its most recent. The current price level -26.26% lower than the highest price of $26.16 marked by the stock while trading over the past 52-weeks, whereas it is 90.03% higher than the lowest price of $10.15 the company dropped to over past 52-weeks. The latest news story on RDUS appeared in Simply Wall St. under the title “Would Shareholders Who Purchased Radius Health’s (NASDAQ:RDUS) Stock Three Years Be Happy With The Share price Today?” on May-11-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -14.98% below one month high and is +0.31% above of the lowest during that time. Looking into the simple moving average, Radius Health Inc. (RDUS)’s stock stands at a SMA-50 of $20.78 while that of 5-day is reading $19.83.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and RDUS’s SMA-200 as of now is $17.43.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Moderate Buy by 8 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.60 for the stock.
Radius Health Inc. Earnings – What Happened With RDUS
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Radius Health Inc. (RDUS) last released financial results for the quarter that ended 3/30/2021, posting a surprise factor of 17.10% for net revenue. During the reported three-month period, company’s sales were $56.26 billion while analysts on average were estimating the same to be $61.39 million.
RDUS – Radius Health Inc. Stock Earnings Estimates
The perspective of Radius Health Inc. (NASDAQ:RDUS)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.41 for stock’s EPS in the current quarter. 6 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was -0.34.
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 46.98 million. RDUS does have institutional investors.
Radius Health Inc. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares. On the other hand, RDUS declared 1,692 shares have been sold in 2 insider transactions over the past three months.
As on Dec 30, 2020, Bellevue Group AG was the top most holder in Radius Health Inc. (NASDAQ:RDUS) with an ownership of 7.53 million shares of the company or 15.94% of the stake worth $134.51 million. The filing also reveals Price (T.Rowe) Associates Inc as the second largest holder in the company with a control over 13.44% of the outstanding shares. Its stake is worth $113.4 million for having 6.35 million shares in hand.
Vanguard Group, Inc. (The) also came holding a key position in the company during the recent quarter and it now holds 9.63% of the outstanding shares. With this there are now 204 institutions which have possession in RDUS’s shares.
Currently, the stock has been recommended as Moderate Buy by 8 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.60 for the stock.